Ascitic complement system in ovarian cancer
نویسندگان
چکیده
منابع مشابه
An ovarian teratocarcinoma as an ascitic tumor.
We have been investigating the pathogenesis of teratocarcinomas, particularly the development of the adult, apparently benign, differentiated struc tures common to them. Although nothing is known concerning the mechanism of the changes involved, we have demonstrated that the differen tiated tissues of a teratocarcinoma are derived from embryonic cell types found within the tumor (12). These emb...
متن کاملHigh Serum and Ascitic Soluble Interleukin-2 Receptor a Levels in Advanced Epithelial Ovarian Cancer
This study was undertaken to determine if advanced epithelial ovarian cancer was associated with increased serum and ascitic levels of soluble interleukin-2 receptor a (slL2Ra). Serum and ascitic fluid samples from 23 ovarian cancer patients were analyzed for slL-2Ra using an enzymelinked immunosorbent assay and compared with the serum and peritoneal levels in 18 normal females. The samples wer...
متن کاملHigh serum and ascitic soluble interleukin-2 receptor alpha levels in advanced epithelial ovarian cancer.
This study was undertaken to determine if advanced epithelial ovarian cancer was associated with increased serum and ascitic levels of soluble interleukin-2 receptor alpha (sIL-2R alpha). Serum and ascitic fluid samples from 23 ovarian cancer patients were analyzed for sIL-2R alpha using an enzyme-linked immunosorbent assay and compared with the serum and peritoneal levels in 18 normal females....
متن کاملInhibition of in Vitro Lymphocyte Function by Cystic and Ascitic Fluids from Ovarian Cancer Patients1
Studies by Badger et aI. (3) have shown that high levels of lymphocyte-inhibitory activity could be found in AF's in the absence of any serum immunosuppressive activity. On this basis, they postulated that tumor cells may locally produce or induce the formation of factors capable of inhibiting lymphocyte function, thus effecting local immunosuppression. It follows that immunosuppressive activit...
متن کاملA phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
PURPOSE To evaluate study feasibility, toxicity, drug concentrations, and activity of escalating doses of the synthetic retinoid fenretinide [N-(4-hydroxyphenyl)retinamide (4-HPR)] in ovarian cancer by measuring serum CA125 and cytomorphometric biomarkers in cancer cells collected from ascitic fluid before and after treatment. METHODS Twenty-two naive patients with ascitic ovarian cancer were...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 2005
ISSN: 0007-0920,1532-1827
DOI: 10.1038/sj.bjc.6602334